Abbott Laboratories (ABT) Shares Outstanding (2009 - 2026)

Abbott Laboratories has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $2.0 billion in Q2 2026.

• Quarterly Shares Outstanding (Entity) changed 0.09% year-over-year to $2.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 billion (changed 0.09% YoY) and the FY2025 annual result came in at $2.0 billion, changed 0.27% from the prior year.
• Shares Outstanding (Entity) held at $2.0 billion in Q2 2026 per ABT's latest filing, from $2.0 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $2.0 billion in Q2 2026 and troughed at $2.0 billion in Q1 2022.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 0.06% in 2022, then gained 0.32% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $2.0 billion in 2022, then increased by 0.07% to $2.0 billion in 2023, then rose by 0.18% to $2.0 billion in 2024, then grew by 0.27% to $2.0 billion in 2025, then advanced by 0.07% to $2.0 billion in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $2.0 billion, $2.0 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.